BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fan Q, Luo G, Yi T, Wang Q, Wang D, Zhang G, Jiang X, Guo X. Diagnostic value of urinary-to-serum human epididymis protein 4 ratio in ovarian cancer. Biomed Rep 2017;7:67-72. [PMID: 28685063 DOI: 10.3892/br.2017.913] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Nalini N, Kumar A, Sharma S, Singh B, Singh AV, Prakash J, Singh S. The Diagnostic Accuracy of Serum and Urine Human Epididymis Protein 4 (HE4) in Ovarian Cancer in 15,394 Subjects: An Updated Meta-Analysis. Cureus 2022. [DOI: 10.7759/cureus.30457] [Reference Citation Analysis]
2 Szymanska B, Lukaszewski Z, Zelazowska-Rutkowska B, Hermanowicz-Szamatowicz K, Gorodkiewicz E. An SPRi Biosensor for Determination of the Ovarian Cancer Marker HE4 in Human Plasma. Sensors (Basel) 2021;21:3567. [PMID: 34065481 DOI: 10.3390/s21103567] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
3 Thomas D, Rathinavel AK, Radhakrishnan P. Altered glycosylation in cancer: A promising target for biomarkers and therapeutics. Biochim Biophys Acta Rev Cancer 2021;1875:188464. [PMID: 33157161 DOI: 10.1016/j.bbcan.2020.188464] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 18.5] [Reference Citation Analysis]